

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.18092448 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95903376 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.70442463 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.45851363 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.33389903 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 5.10716751 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.09972986 |
| 8 | vocalization behavior (GO:0071625) | 5.06793311 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.00091268 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.77375202 |
| 11 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.72932857 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.71575163 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.71505189 |
| 14 | sodium ion export (GO:0071436) | 4.69959791 |
| 15 | glutamate secretion (GO:0014047) | 4.67555638 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.61311102 |
| 17 | protein localization to synapse (GO:0035418) | 4.52077417 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.37401170 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.37363307 |
| 20 | exploration behavior (GO:0035640) | 4.35787680 |
| 21 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.33760803 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.33054447 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 4.32712279 |
| 24 | positive regulation of dendritic spine development (GO:0060999) | 4.27473020 |
| 25 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.22294224 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.18936310 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.18388431 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 4.15352088 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.12419394 |
| 30 | behavioral response to cocaine (GO:0048148) | 4.11412434 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.09307590 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 4.08702947 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.04010519 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 4.01030683 |
| 35 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.98042780 |
| 36 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.97869832 |
| 37 | proline transport (GO:0015824) | 3.97010339 |
| 38 | L-amino acid import (GO:0043092) | 3.94648517 |
| 39 | response to histamine (GO:0034776) | 3.93862630 |
| 40 | long-term memory (GO:0007616) | 3.92944209 |
| 41 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.89308910 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.88412444 |
| 43 | response to auditory stimulus (GO:0010996) | 3.86404643 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.86257319 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.85005794 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.84515484 |
| 47 | cell communication by electrical coupling (GO:0010644) | 3.83860576 |
| 48 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.82726036 |
| 49 | regulation of dendritic spine development (GO:0060998) | 3.76468687 |
| 50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.74374238 |
| 51 | prepulse inhibition (GO:0060134) | 3.74055844 |
| 52 | auditory behavior (GO:0031223) | 3.72534027 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.72072728 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.69972437 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.62083249 |
| 56 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.61905142 |
| 57 | neurotransmitter transport (GO:0006836) | 3.58821713 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.58267839 |
| 59 | long-term synaptic potentiation (GO:0060291) | 3.50789250 |
| 60 | potassium ion homeostasis (GO:0055075) | 3.50493431 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.49925658 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.49183225 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.49081432 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.48407029 |
| 65 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.47916117 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.47821148 |
| 67 | neuromuscular process controlling posture (GO:0050884) | 3.47519282 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 3.45744699 |
| 69 | transmission of nerve impulse (GO:0019226) | 3.44539596 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.42354627 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 3.41586225 |
| 72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.39041221 |
| 73 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.37952001 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 3.36603554 |
| 75 | amino acid import (GO:0043090) | 3.36195264 |
| 76 | potassium ion import (GO:0010107) | 3.35230012 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.34941851 |
| 78 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.34561494 |
| 79 | central nervous system myelination (GO:0022010) | 3.33726477 |
| 80 | axon ensheathment in central nervous system (GO:0032291) | 3.33726477 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 3.32238776 |
| 82 | presynaptic membrane organization (GO:0097090) | 3.29042933 |
| 83 | striatum development (GO:0021756) | 3.27074602 |
| 84 | glycine transport (GO:0015816) | 3.26996987 |
| 85 | membrane hyperpolarization (GO:0060081) | 3.26973250 |
| 86 | alanine transport (GO:0032328) | 3.26123494 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 3.24209506 |
| 88 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.23730498 |
| 89 | neurotransmitter uptake (GO:0001504) | 3.23425610 |
| 90 | activation of protein kinase A activity (GO:0034199) | 3.23352451 |
| 91 | acidic amino acid transport (GO:0015800) | 3.23277792 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 3.22618855 |
| 93 | positive regulation of neurotransmitter transport (GO:0051590) | 3.22170762 |
| 94 | C4-dicarboxylate transport (GO:0015740) | 3.17683386 |
| 95 | regulation of vesicle fusion (GO:0031338) | 3.16364544 |
| 96 | behavioral fear response (GO:0001662) | 3.12536655 |
| 97 | behavioral defense response (GO:0002209) | 3.12536655 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.12468304 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 3.10426993 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.09486405 |
| 101 | visual learning (GO:0008542) | 3.09243238 |
| 102 | cell migration in hindbrain (GO:0021535) | 3.08283778 |
| 103 | neuromuscular process (GO:0050905) | 3.07830388 |
| 104 | potassium ion transmembrane transport (GO:0071805) | 3.07249163 |
| 105 | cellular potassium ion transport (GO:0071804) | 3.07249163 |
| 106 | dendrite morphogenesis (GO:0048813) | 3.06659036 |
| 107 | fear response (GO:0042596) | 3.05192454 |
| 108 | visual behavior (GO:0007632) | 3.04978354 |
| 109 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.04418591 |
| 110 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.04418591 |
| 111 | learning (GO:0007612) | 3.02781603 |
| 112 | postsynaptic membrane organization (GO:0001941) | 2.98903936 |
| 113 | membrane depolarization during action potential (GO:0086010) | 2.97779096 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.97348894 |
| 115 | membrane depolarization (GO:0051899) | 2.97314400 |
| 116 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.96691699 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.95119905 |
| 118 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92669695 |
| 119 | synaptic transmission (GO:0007268) | 2.90600134 |
| 120 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.89764791 |
| 121 | synapse assembly (GO:0007416) | 2.89660523 |
| 122 | membrane repolarization (GO:0086009) | 2.89082858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.12939127 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25941605 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.19913093 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14890152 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97741130 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.81111230 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76374507 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76374507 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75317519 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.73903875 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70368467 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61637210 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61053089 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60325099 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59400887 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.48923720 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46250740 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40207384 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35538878 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.33726603 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33150448 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29087064 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28250379 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24684657 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03475253 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03405823 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01495725 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98919286 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93461781 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70292551 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65014287 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57362120 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55128974 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46407808 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40739605 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38111395 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37916126 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37451528 |
| 39 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32309554 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31943447 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29326508 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28545599 |
| 43 | AR_19668381_ChIP-Seq_PC3_Human | 1.26529526 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26020507 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25470385 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25178628 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25057496 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25016791 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23124986 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20539159 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19592706 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18655414 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17765727 |
| 54 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17624842 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17094896 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16349732 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15649649 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13154315 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12986692 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12739280 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12179100 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11134853 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10829380 |
| 64 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10409840 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09775676 |
| 66 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08726384 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06571256 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04184754 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03084796 |
| 70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02824315 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02422982 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02241824 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01394294 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01081295 |
| 75 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00852889 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00188034 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99759818 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99181827 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98528036 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98188850 |
| 81 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.97915891 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96953704 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96933402 |
| 84 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.96024992 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95800931 |
| 86 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95691933 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95508325 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94662156 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94635327 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94364612 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93286759 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91488314 |
| 93 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91337712 |
| 94 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90974589 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90057231 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89393417 |
| 97 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88545972 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88474966 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88434101 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87813758 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87638394 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86917932 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86730705 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86008731 |
| 105 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85286519 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85131713 |
| 107 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84632629 |
| 108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84477240 |
| 109 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84309427 |
| 110 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83352240 |
| 111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82597424 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82540058 |
| 113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82539511 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81205806 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79098877 |
| 116 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78096903 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77814315 |
| 118 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76725302 |
| 119 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.76259921 |
| 120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76205796 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.75831327 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75831327 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74418359 |
| 124 | KDM2B_26808549_Chip-Seq_REH_Human | 0.74136794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.28602257 |
| 2 | MP0003880_abnormal_central_pattern | 4.22161950 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.10798305 |
| 4 | MP0002822_catalepsy | 4.09550377 |
| 5 | MP0009745_abnormal_behavioral_response | 3.48853275 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.32183752 |
| 7 | MP0002064_seizures | 3.23162989 |
| 8 | MP0009046_muscle_twitch | 3.21981839 |
| 9 | MP0004270_analgesia | 3.10861087 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.02018787 |
| 11 | MP0001486_abnormal_startle_reflex | 2.92034383 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.85714950 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.66498210 |
| 14 | MP0002272_abnormal_nervous_system | 2.57812069 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.37314747 |
| 16 | MP0005646_abnormal_pituitary_gland | 2.28181870 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.20137307 |
| 18 | MP0008569_lethality_at_weaning | 2.19178547 |
| 19 | MP0001984_abnormal_olfaction | 2.18416612 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.16580095 |
| 21 | MP0002736_abnormal_nociception_after | 1.97727751 |
| 22 | MP0003329_amyloid_beta_deposits | 1.94562731 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.92223773 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.89541634 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.88266728 |
| 26 | MP0004885_abnormal_endolymph | 1.84347152 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.83337328 |
| 28 | MP0004858_abnormal_nervous_system | 1.81322944 |
| 29 | MP0001970_abnormal_pain_threshold | 1.80484568 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.80471438 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.77756337 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.74128869 |
| 33 | MP0004924_abnormal_behavior | 1.74128869 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.72135373 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.60629864 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.59702387 |
| 37 | MP0001529_abnormal_vocalization | 1.55718537 |
| 38 | MP0003690_abnormal_glial_cell | 1.53499533 |
| 39 | MP0003633_abnormal_nervous_system | 1.53348334 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.53306132 |
| 41 | MP0002184_abnormal_innervation | 1.50086503 |
| 42 | MP0003879_abnormal_hair_cell | 1.49626065 |
| 43 | MP0000778_abnormal_nervous_system | 1.42968793 |
| 44 | MP0000955_abnormal_spinal_cord | 1.40151252 |
| 45 | MP0003787_abnormal_imprinting | 1.39979642 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.39862469 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.38585060 |
| 48 | MP0002090_abnormal_vision | 1.35473474 |
| 49 | MP0003123_paternal_imprinting | 1.30936988 |
| 50 | MP0004142_abnormal_muscle_tone | 1.29511637 |
| 51 | MP0003075_altered_response_to | 1.27165559 |
| 52 | MP0003631_nervous_system_phenotype | 1.26725951 |
| 53 | MP0001905_abnormal_dopamine_level | 1.17407744 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.16581498 |
| 55 | MP0002229_neurodegeneration | 1.13915871 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.11542641 |
| 57 | MP0003122_maternal_imprinting | 1.07793460 |
| 58 | MP0002152_abnormal_brain_morphology | 1.06682828 |
| 59 | MP0008872_abnormal_physiological_respon | 1.04400046 |
| 60 | MP0003634_abnormal_glial_cell | 1.03330992 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.00691242 |
| 62 | MP0008874_decreased_physiological_sensi | 0.99204757 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.97894887 |
| 64 | MP0000751_myopathy | 0.95736431 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.95588289 |
| 66 | MP0001177_atelectasis | 0.94925361 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.92159687 |
| 68 | MP0000013_abnormal_adipose_tissue | 0.91974852 |
| 69 | MP0003632_abnormal_nervous_system | 0.90260049 |
| 70 | MP0000604_amyloidosis | 0.89304470 |
| 71 | MP0005394_taste/olfaction_phenotype | 0.88721507 |
| 72 | MP0005499_abnormal_olfactory_system | 0.88721507 |
| 73 | MP0000920_abnormal_myelination | 0.87563734 |
| 74 | MP0004742_abnormal_vestibular_system | 0.85075738 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 0.85062434 |
| 76 | MP0005253_abnormal_eye_physiology | 0.84607363 |
| 77 | MP0004085_abnormal_heartbeat | 0.83049579 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.81919086 |
| 79 | MP0005535_abnormal_body_temperature | 0.81798449 |
| 80 | MP0004215_abnormal_myocardial_fiber | 0.81249687 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.80600985 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.79294090 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.77345060 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.76911250 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.76644064 |
| 86 | MP0001188_hyperpigmentation | 0.75376967 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.74779143 |
| 88 | MP0004233_abnormal_muscle_weight | 0.73334473 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.73129216 |
| 90 | MP0004510_myositis | 0.73049397 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.73027950 |
| 92 | MP0004147_increased_porphyrin_level | 0.69116936 |
| 93 | MP0000566_synostosis | 0.68423281 |
| 94 | MP0003646_muscle_fatigue | 0.65172878 |
| 95 | MP0000026_abnormal_inner_ear | 0.62692193 |
| 96 | MP0003283_abnormal_digestive_organ | 0.62009956 |
| 97 | MP0004043_abnormal_pH_regulation | 0.61546948 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.59695828 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.58188641 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.57636016 |
| 101 | MP0000579_abnormal_nail_morphology | 0.56216776 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.55825008 |
| 103 | MP0001664_abnormal_digestion | 0.55111839 |
| 104 | MP0005409_darkened_coat_color | 0.54850725 |
| 105 | MP0005171_absent_coat_pigmentation | 0.54491837 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.53841494 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.53469097 |
| 108 | MP0003956_abnormal_body_size | 0.53118434 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 0.51582473 |
| 110 | MP0004130_abnormal_muscle_cell | 0.51121243 |
| 111 | MP0005166_decreased_susceptibility_to | 0.50964670 |
| 112 | MP0010769_abnormal_survival | 0.50463660 |
| 113 | MP0005195_abnormal_posterior_eye | 0.50273572 |
| 114 | MP0010770_preweaning_lethality | 0.48458447 |
| 115 | MP0002082_postnatal_lethality | 0.48458447 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.48329178 |
| 117 | MP0010768_mortality/aging | 0.46994514 |
| 118 | MP0001943_abnormal_respiration | 0.46518130 |
| 119 | MP0003938_abnormal_ear_development | 0.46086545 |
| 120 | MP0000747_muscle_weakness | 0.44776911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.49416528 |
| 2 | Myokymia (HP:0002411) | 7.44652911 |
| 3 | Focal seizures (HP:0007359) | 5.44299316 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.01002577 |
| 5 | Visual hallucinations (HP:0002367) | 4.66653744 |
| 6 | Action tremor (HP:0002345) | 4.54592244 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.49708901 |
| 8 | Absence seizures (HP:0002121) | 4.27560792 |
| 9 | Febrile seizures (HP:0002373) | 4.07096020 |
| 10 | Atonic seizures (HP:0010819) | 4.02336158 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.01184382 |
| 12 | Dialeptic seizures (HP:0011146) | 3.88297082 |
| 13 | Dysdiadochokinesis (HP:0002075) | 3.84164007 |
| 14 | Depression (HP:0000716) | 3.67226042 |
| 15 | Megalencephaly (HP:0001355) | 3.53129466 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.47008145 |
| 17 | Postural instability (HP:0002172) | 3.45693709 |
| 18 | Ankle clonus (HP:0011448) | 3.44634471 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.39464547 |
| 20 | Anxiety (HP:0000739) | 3.36364117 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.27712695 |
| 22 | Sensory axonal neuropathy (HP:0003390) | 3.24066185 |
| 23 | Poor eye contact (HP:0000817) | 3.24062153 |
| 24 | Delusions (HP:0000746) | 3.24054953 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.24039057 |
| 26 | Hemiplegia (HP:0002301) | 3.19357632 |
| 27 | Hemiparesis (HP:0001269) | 3.17564317 |
| 28 | Torticollis (HP:0000473) | 3.15963586 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 3.13749352 |
| 30 | Dysmetria (HP:0001310) | 3.07920326 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.06434684 |
| 32 | Apathy (HP:0000741) | 3.06189295 |
| 33 | Truncal ataxia (HP:0002078) | 3.05353586 |
| 34 | Abnormal social behavior (HP:0012433) | 3.04905435 |
| 35 | Impaired social interactions (HP:0000735) | 3.04905435 |
| 36 | Broad-based gait (HP:0002136) | 3.00460120 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.99323825 |
| 38 | Abnormality of binocular vision (HP:0011514) | 2.93308546 |
| 39 | Diplopia (HP:0000651) | 2.93308546 |
| 40 | Neurofibrillary tangles (HP:0002185) | 2.89564125 |
| 41 | Genetic anticipation (HP:0003743) | 2.86530733 |
| 42 | Mutism (HP:0002300) | 2.83882797 |
| 43 | Akinesia (HP:0002304) | 2.81500483 |
| 44 | Status epilepticus (HP:0002133) | 2.79349565 |
| 45 | Focal dystonia (HP:0004373) | 2.79271551 |
| 46 | Diminished motivation (HP:0000745) | 2.77785414 |
| 47 | Spastic tetraparesis (HP:0001285) | 2.73618788 |
| 48 | Aplasia involving bones of the extremities (HP:0009825) | 2.72283451 |
| 49 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.72283451 |
| 50 | Aplasia of the phalanges of the hand (HP:0009802) | 2.72283451 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.71248454 |
| 52 | Bradykinesia (HP:0002067) | 2.67190481 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.60754894 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.60754894 |
| 55 | Intention tremor (HP:0002080) | 2.60004179 |
| 56 | Hyperventilation (HP:0002883) | 2.59501376 |
| 57 | Craniofacial dystonia (HP:0012179) | 2.57635882 |
| 58 | Scanning speech (HP:0002168) | 2.57355534 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.55291744 |
| 60 | Peripheral hypomyelination (HP:0007182) | 2.53355857 |
| 61 | Stereotypic behavior (HP:0000733) | 2.52621979 |
| 62 | Papilledema (HP:0001085) | 2.52075751 |
| 63 | Dysmetric saccades (HP:0000641) | 2.51241363 |
| 64 | Spastic gait (HP:0002064) | 2.48879590 |
| 65 | Increased circulating renin level (HP:0000848) | 2.47534561 |
| 66 | Polyphagia (HP:0002591) | 2.43522845 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.40628440 |
| 68 | Annular pancreas (HP:0001734) | 2.39479630 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.39269297 |
| 70 | Urinary urgency (HP:0000012) | 2.39074659 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.36089776 |
| 72 | Choreoathetosis (HP:0001266) | 2.35200281 |
| 73 | Central scotoma (HP:0000603) | 2.35007058 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.31076954 |
| 75 | Abnormality of the lower motor neuron (HP:0002366) | 2.30832955 |
| 76 | Drooling (HP:0002307) | 2.30547823 |
| 77 | Excessive salivation (HP:0003781) | 2.30547823 |
| 78 | Impaired smooth pursuit (HP:0007772) | 2.28396153 |
| 79 | Split foot (HP:0001839) | 2.26179361 |
| 80 | Impaired vibratory sensation (HP:0002495) | 2.24140578 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.23129586 |
| 82 | Abnormal EKG (HP:0003115) | 2.21820009 |
| 83 | Congenital stationary night blindness (HP:0007642) | 2.19831791 |
| 84 | Prolonged QT interval (HP:0001657) | 2.18234589 |
| 85 | Sleep apnea (HP:0010535) | 2.18131438 |
| 86 | Rigidity (HP:0002063) | 2.17110412 |
| 87 | Pointed chin (HP:0000307) | 2.16952560 |
| 88 | Generalized myoclonic seizures (HP:0002123) | 2.15737291 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.15155522 |
| 90 | Lower limb muscle weakness (HP:0007340) | 2.12325733 |
| 91 | Amblyopia (HP:0000646) | 2.11150321 |
| 92 | Clumsiness (HP:0002312) | 2.09816104 |
| 93 | Hypsarrhythmia (HP:0002521) | 2.08777254 |
| 94 | Incomplete penetrance (HP:0003829) | 2.03663210 |
| 95 | Clonus (HP:0002169) | 2.02011186 |
| 96 | Insomnia (HP:0100785) | 2.01343225 |
| 97 | Rapidly progressive (HP:0003678) | 2.00601215 |
| 98 | Limb dystonia (HP:0002451) | 1.98070013 |
| 99 | Pheochromocytoma (HP:0002666) | 1.97812500 |
| 100 | Fetal akinesia sequence (HP:0001989) | 1.95157520 |
| 101 | Abnormality of saccadic eye movements (HP:0000570) | 1.94387577 |
| 102 | Memory impairment (HP:0002354) | 1.89943820 |
| 103 | Tetraplegia (HP:0002445) | 1.89824272 |
| 104 | Psychosis (HP:0000709) | 1.89418575 |
| 105 | Spinal canal stenosis (HP:0003416) | 1.89048419 |
| 106 | Resting tremor (HP:0002322) | 1.88661920 |
| 107 | Blue irides (HP:0000635) | 1.88485328 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.88069006 |
| 109 | Gait ataxia (HP:0002066) | 1.85974394 |
| 110 | CNS hypomyelination (HP:0003429) | 1.82527758 |
| 111 | Progressive inability to walk (HP:0002505) | 1.81221096 |
| 112 | Bundle branch block (HP:0011710) | 1.81002132 |
| 113 | Limb ataxia (HP:0002070) | 1.80965160 |
| 114 | Abnormality of the periventricular white matter (HP:0002518) | 1.79407044 |
| 115 | Dementia (HP:0000726) | 1.77883278 |
| 116 | Postural tremor (HP:0002174) | 1.76374152 |
| 117 | Ankyloglossia (HP:0010296) | 1.75766874 |
| 118 | Neoplasm of the heart (HP:0100544) | 1.75481237 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.74386740 |
| 120 | Severe global developmental delay (HP:0011344) | 1.70080126 |
| 121 | Scotoma (HP:0000575) | 1.69448750 |
| 122 | Absent speech (HP:0001344) | 1.65003755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.49408099 |
| 2 | NTRK3 | 4.08078745 |
| 3 | MAP3K9 | 3.38196719 |
| 4 | PRKD3 | 2.73502390 |
| 5 | MAP3K4 | 2.59607511 |
| 6 | NTRK2 | 2.46546644 |
| 7 | MINK1 | 2.45569131 |
| 8 | DAPK2 | 2.30690592 |
| 9 | MARK1 | 2.29822209 |
| 10 | MAP2K7 | 2.24009023 |
| 11 | PAK6 | 2.20983061 |
| 12 | TNIK | 2.06113959 |
| 13 | KSR2 | 2.01500639 |
| 14 | CAMKK1 | 2.01398137 |
| 15 | PRPF4B | 1.69826324 |
| 16 | NTRK1 | 1.69198550 |
| 17 | IRAK2 | 1.65559186 |
| 18 | MAP2K4 | 1.64636080 |
| 19 | STK38 | 1.56823136 |
| 20 | CDK5 | 1.54598646 |
| 21 | SGK223 | 1.49339751 |
| 22 | SGK494 | 1.49339751 |
| 23 | RIPK4 | 1.46728700 |
| 24 | MAP3K13 | 1.45311099 |
| 25 | PHKG1 | 1.44287172 |
| 26 | PHKG2 | 1.44287172 |
| 27 | SGK2 | 1.43991285 |
| 28 | KSR1 | 1.43554740 |
| 29 | LMTK2 | 1.40480979 |
| 30 | FES | 1.40387861 |
| 31 | ARAF | 1.39098784 |
| 32 | MAP3K12 | 1.35633050 |
| 33 | PINK1 | 1.33697861 |
| 34 | SGK3 | 1.26871119 |
| 35 | MAPK13 | 1.25500005 |
| 36 | DAPK1 | 1.23958849 |
| 37 | PRKCG | 1.17616671 |
| 38 | PLK2 | 1.14512496 |
| 39 | PRKCH | 1.10405658 |
| 40 | SIK2 | 1.09911878 |
| 41 | CASK | 1.09634362 |
| 42 | CDK19 | 1.06957737 |
| 43 | CAMKK2 | 1.06152936 |
| 44 | TYRO3 | 1.02034067 |
| 45 | CAMK1 | 0.99387248 |
| 46 | GRK5 | 0.97460343 |
| 47 | TAOK1 | 0.96366522 |
| 48 | MUSK | 0.96231283 |
| 49 | UHMK1 | 0.94203005 |
| 50 | CDK18 | 0.93483985 |
| 51 | CDK15 | 0.92553328 |
| 52 | CAMK2A | 0.91094806 |
| 53 | CDK14 | 0.88569544 |
| 54 | TNK2 | 0.87605633 |
| 55 | MAP3K2 | 0.87368599 |
| 56 | TRIB3 | 0.83921680 |
| 57 | BRD4 | 0.83161982 |
| 58 | MARK2 | 0.81432646 |
| 59 | ALK | 0.80737407 |
| 60 | CDK11A | 0.79962776 |
| 61 | DAPK3 | 0.78975298 |
| 62 | SGK1 | 0.76859124 |
| 63 | STK11 | 0.74004539 |
| 64 | RAF1 | 0.72837782 |
| 65 | PAK3 | 0.70596278 |
| 66 | RIPK1 | 0.69124771 |
| 67 | DYRK1A | 0.67789286 |
| 68 | CAMK1G | 0.66459540 |
| 69 | MAP3K7 | 0.66271970 |
| 70 | PKN1 | 0.65996442 |
| 71 | PDK1 | 0.65696518 |
| 72 | PDPK1 | 0.65565773 |
| 73 | NEK6 | 0.64258569 |
| 74 | CAMK2B | 0.62883742 |
| 75 | NEK1 | 0.62121479 |
| 76 | RET | 0.62045976 |
| 77 | WNK3 | 0.61248558 |
| 78 | BRAF | 0.59472260 |
| 79 | CAMK1D | 0.57382507 |
| 80 | RPS6KA3 | 0.56774261 |
| 81 | PNCK | 0.56745207 |
| 82 | MAP3K11 | 0.55605522 |
| 83 | OXSR1 | 0.55169641 |
| 84 | MAP3K1 | 0.55023899 |
| 85 | SIK3 | 0.54949952 |
| 86 | MOS | 0.54148298 |
| 87 | LIMK1 | 0.53389032 |
| 88 | PRKCE | 0.52001015 |
| 89 | CAMK4 | 0.51287453 |
| 90 | PRKCZ | 0.48244173 |
| 91 | PDK2 | 0.48066310 |
| 92 | CCNB1 | 0.47494603 |
| 93 | DMPK | 0.47268776 |
| 94 | BMPR2 | 0.46615278 |
| 95 | LATS2 | 0.46274906 |
| 96 | TAOK2 | 0.44904327 |
| 97 | MAPK10 | 0.44738627 |
| 98 | CDC42BPA | 0.43751581 |
| 99 | FYN | 0.43173885 |
| 100 | CAMK2G | 0.43025832 |
| 101 | CAMK2D | 0.41297020 |
| 102 | MAPK12 | 0.39839037 |
| 103 | PTK2B | 0.39191779 |
| 104 | PRKD2 | 0.39139315 |
| 105 | PRKCA | 0.39136112 |
| 106 | ADRBK1 | 0.38419340 |
| 107 | CSNK1G2 | 0.37519258 |
| 108 | WNK1 | 0.36656631 |
| 109 | PRKCB | 0.35582448 |
| 110 | MAP2K1 | 0.34193219 |
| 111 | BRSK1 | 0.33588804 |
| 112 | PRKCQ | 0.30080807 |
| 113 | ERBB3 | 0.28320870 |
| 114 | JAK2 | 0.26598009 |
| 115 | MAP2K6 | 0.24414631 |
| 116 | TESK1 | 0.22156042 |
| 117 | PRKCD | 0.21965925 |
| 118 | RPS6KB1 | 0.20889236 |
| 119 | SRC | 0.19332274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73635610 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49473419 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.32009670 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.98895963 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78362395 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.64121608 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.61710820 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.55777383 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53746057 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.27222860 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25386312 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.10799871 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.09964813 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.02249095 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96103990 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90101093 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85020891 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81057077 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77638884 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65759655 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59173559 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56131601 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53511361 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.52548069 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.51039212 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47493421 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43738939 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.38127532 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.30902779 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25264641 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22839994 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21572876 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19784417 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.19083815 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18182061 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11236550 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04231675 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 0.96922466 |
| 39 | Glioma_Homo sapiens_hsa05214 | 0.95955938 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94914875 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94362240 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94111733 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93491672 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90273761 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87919418 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.84614049 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84240780 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84110315 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.83902155 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82862860 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82661944 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80481067 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79929621 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79691728 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76869541 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76110657 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.74551551 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72698702 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72384941 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71962455 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66964110 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66722792 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66318478 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64566366 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64056328 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61311114 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61095843 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57984666 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57599663 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56731423 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54636016 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53570741 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53443940 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51638217 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50891064 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50050537 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48237786 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48080730 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47438342 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46991226 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.46971990 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46628169 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45865465 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42866789 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.41841925 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41835814 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40599675 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38739660 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38482160 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.38078837 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37892339 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37789813 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36788817 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.34667942 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34184774 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32368966 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32036476 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30820014 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29857219 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29849647 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29229946 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27646875 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26942356 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26584566 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.24435195 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22906754 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20639169 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.19591866 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16853347 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15317795 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.15075225 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14698949 |

